Answers are grounded in this paper and cite their sources.
Whether low-virulence bacteria contribute to intervertebral disc degeneration remains uncertain. This narrative review examines human microbiological findings, antibiotic trials, animal models, and mechanistic studies, to distinguish evidence of infection from colonization or contamination. Cutibacterium acnes ( C. acnes ) is the organism studied most extensively. Culture, polymerase chain reaction, histology, fluorescence in situ hybridization, and immunohistochemistry have detected bacteria or bacterial components in some human discs. However, results vary and are difficult to interpret in low-biomass specimens vulnerable to contamination. Intracellular bacterial signals do not establish host-cell identity or the presence of viable organisms. Human studies have not established whether bacterial entry precedes degeneration. In experimental models, C. acnes can induce inflammation, cell loss, matrix degradation, and endplate or marrow injury, but direct inoculation and procedural injury limit extrapolation to human disease. Antibiotic trials have yielded mixed results. Low-certainty evidence suggests slight pain relief and small-to-moderate improvement in disability at 12–14 weeks with oral antibiotics in patients with Modic type 1 changes and disc herniation. These findings do not establish a basis for routine prolonged treatment. Trials did not require microbiological confirmation of intradiscal infection, so any benefit cannot be attributed specifically to treatment of infection. Current evidence does not justify routine prolonged empirical treatment based solely on Modic changes or a single positive culture. The “damage–infection–accelerated degeneration” and transient “hit-and-run” models remain hypotheses without longitudinal human confirmation. Animal culture-negative endpoints do not establish bacterial eradication or continued degeneration after clearance. Longitudinal studies should examine the sequence of barrier injury, bacterial entry, and degeneration using contamination-controlled assessments of microbial viability, tissue localization, and host response. Host-response markers require validation before use in patient selection.
No takes yet. Share an insight, caveat, or question.
Tong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: